Literature DB >> 11348038

Cardiac sympathetic dysfunction in an athlete's heart detected by 123I-metaiodobenzylguanidine scintigraphy.

S Matsuo1, Y Nakamura, M Takahashi, T Matsui, J Kusukawa, S Yoshida, H Hamamoto, M Kinoshita.   

Abstract

The athlete's heart is commonly characterized by an increase in left ventricular mass because of an increase in the left ventricular diastolic cavity dimensions or wall thickness or both. Endurance exercise also induces numerous cardiovascular adaptations, including increased vagal tone. However, the sympathetic function has not yet been precisely elucidated, so the present study evaluated cardiac sympathetic nerve function from metaiodobenzylguanidine (MIBG) images obtained 15 and 180 min after the injection of 123I-MIBG at a dose of 111 MBq. The ratio of heart/mediastinum count (H/M) and the washout rates of 123I-MIBG (WR) were calculated in 25 consecutive patients who were athletes (aged 52+/-13 years) and 23 normal subjects. There was a significant difference in the H/M between the athletic and normal hearts (2.3+/-0.3 vs 2.6+/-0.3, p<0.01, Scheffe's test). An increased WR was observed in the athletes group when compared with the normal group (34+/-4 vs 28+/-3, p<0.01), and there was a significant correlation between WR and the left ventricular mass index (r=0.578, p<0.01). Prolonged exercise training may alter cardiac sympathetic nerve function, which can be detected by MIBG imaging.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348038     DOI: 10.1253/jcj.65.371

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  9 in total

Review 1.  Ionic mechanisms and vectorial model of early repolarization pattern in the surface electrocardiogram of the athlete.

Authors:  Eduardo C Barbosa; Alfredo de S Bomfim; Paulo R Benchimol-Barbosa; Paulo Ginefra
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-07       Impact factor: 1.468

2.  Clinical use of nuclear cardiology in the assessment of heart failure.

Authors:  Shinro Matsuo; Kenichi Nakajima; Seigo Kinuya
Journal:  World J Cardiol       Date:  2010-10-26

3.  A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies.

Authors:  Shinro Matsuo; Ichiro Nakae; Takayoshi Tsutamoto; Noriake Okamoto; Minoru Horie
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

4.  Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy.

Authors:  Shinro Matsuo; Yasuyuki Nakamura; Takayoshi Tsutamoto; Masahiko Kinoshita
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

5.  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.

Authors:  Shinro Matsuo; Kenichi Nakajima; Koichi Okuda; Masaya Kawano; Takehiro Ishikawa; Tetsuo Hosoya; Junichi Taki; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-07       Impact factor: 9.236

6.  Prognostic value of iodine-123 metaiodobenzylguanidine imaging in patients with heart failure.

Authors:  Shinro Matsuo; Yasuyuki Nakamura; Tetsuya Matsumoto; Ichiro Nakae; Kiyoshi Murata; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2003

7.  Poststress left ventricular function in patients with coronary artery disease measured by Tl-201 ECG-gated SPECT.

Authors:  Shinro Matsuo; Yasuyuki Nakamura; Masahiko Kinoshita
Journal:  Exp Clin Cardiol       Date:  2002

8.  The role of impaired sympathetic nerve function in enhancing coronary vasoconstriction in patients with hypertrophic cardiomyopathy.

Authors:  Shinro Matsuo; Tetsuya Matsumoto; Ichiro Nakae; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2007

9.  Differential effects of variation in athletes training on myocardial morphophysiological adaptation in men: focus on ¹²³I-MIBG assessed myocardial sympathetic activity.

Authors:  Douglas Pinheiro Miranda; Marcelo José dos Santos; Vera Maria Cury Salemi; Edmundo Pereira Caparelli de Oliveira; Hein J Verberne; Euclides Timóteo da Rocha
Journal:  J Nucl Cardiol       Date:  2014-03-14       Impact factor: 5.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.